已收盘 03-28 16:00:00 美东时间
-0.070
-2.87%
New investment marks expansion of corporate strategy to utilize significant cash position to create additional shareholder valuePharmaCyte Biotech, Inc. (NASDAQ:PMCB) ("PharmaCyte" or the "Company") announces it has made
2023-11-15 21:34
Femasys Secures $6.85M Additional Financing With Strategic Investment From Inve...
2023-11-15 08:32
Company prepares for comprehensive discussion with FDA to determine appropriate next steps for technology while evaluating additional opportunitiesPharmaCyte Biotech, Inc. (NASDAQ:PMCB) ("PharmaCyte" or the "Company")
2023-10-31 21:22
On Tuesday, 386 stocks made new 52-week lows.
2023-09-27 00:04
Cortexyme (NASDAQ:CRTX – Get Rating) and PharmaCyte Biotech (OTCMKTS:PMCB – Get...
2023-04-13 04:42
PharmaCyte Biotech Inc (OTCMKTS:PMCBD – Get Rating) shares traded up 0.4% on Tu...
2023-03-31 04:02
PharmaCyte Biotech Inc (OTCMKTS:PMCBD – Get Rating)'s stock price traded up 0.4...
2023-03-29 14:04
PharmaCyte Biotech (OTCMKTS:PMCBD – Get Rating) and Vericel (NASDAQ:VCEL – Get ...
2023-03-10 14:25
PharmaCyte Biotech Inc (OTCMKTS:PMCBD – Get Rating) shares shot up 0.7% during ...
2023-01-18 14:52
Ambrx Biopharma (NYSE:AMAM – Get Rating) and PharmaCyte Biotech (OTCMKTS:PMCBD ...
2023-01-02 14:21